Pulmonary Hypertension

March 31, 2015November 5, 2015

Opsumit Granted Marketing Approval in Japan for PAH

The Japanese Ministry of Health Labor and Welfare has granted marketing approval for a novel therapy developed by Actelion for pulmonary arterial hypertension (PAH). Opsumit (macitentan) was approved based on the latest data ... Read more

March 30, 2015November 5, 2015

Researchers Find Pulmonary Hypertension Drug Sildenafil Has No Significant Impact on Cardiac Function

News, Pulmonary Hypertension

Researchers at the Hospital Ana Neri in Federal University of Bahia in Brazil found that the medication Sildenafil appears to have no immediate impact on cardiac function in patients with heart failure. ... Read more

March 27, 2015November 5, 2015

Serial Risk Score For Pulmonary Arterial Hypertension Helps Predict Disease Outcomes

News, Pulmonary Hypertension

In a recent study entitled “Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management ... Read more

March 25, 2015November 5, 2015

No Clear Benefits from Inhaled Nitric Oxide (iNO) for Pulmonary Hypertension in Preterm Babies

News, Pulmonary Hypertension

Inhaled Nitric Oxide (iNO) remains the standard therapy for severe respiratory failure due to pulmonary hypertension in preterm neonates. These are the findings based on a recent study entitled “Off-Label Use ... Read more

March 24, 2015November 5, 2015

Pulmokine Receives $1 Million To Advance PAH Candidate Into Clinical Trial

Pulmonary Hypertension

Pulmokine recently announced that it has entered into an investment agreement with Broadview Ventures for $1 Million. Resulting proceeds will be utilized to develop PK10571, Pulmokine’s lead candidate, in Phase 1 clinical trials to address patients ... Read more

March 23, 2015November 5, 2015

Long-term Data on Selexipag for PAH Presented at American College of Cardiology (ACC) 2015

News, Pulmonary Hypertension

Actelion Ltd recently presented long-term results at the American College of Cardiology (ACC) Congress in San Diego, US from their pivotal selexipag (Uptravi®) Phase III GRIPHON trial. The company reported that, ... Read more

March 19, 2015November 5, 2015

Computed Tomography Pulmonary Angiography Measurements Shown as a Predictive Tool for Pulmonary Hypertension

News, Pulmonary Hypertension

Researchers at the VU University Medical Center in Amsterdam, The Netherlands recently published findings in The International Journal of Cardiovascular Imaging that reveal specific measurements obtained by standard computed tomography ... Read more

March 18, 2015November 5, 2015

Glucose Metabolic Pathway Facilitates Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension

News, Pulmonary Hypertension

A research team from the Lerner Research Institute at the Cleveland Clinic recently discovered that a particular enzyme that is part of protein modification through a glucose metabolism pathway (HBP) might ... Read more

March 10, 2015November 5, 2015

Researchers Review Importance of Non-Invasive Imaging in Diagnosis and Management of PAH

News, Pulmonary Hypertension

A recently accepted manuscript on the Canadian Journal of Cardiology, an open access journal, provides an overview of the current clinical use of noninvasive imagining techniques, such as echocardiography, for pulmonary ... Read more

March 9, 2015November 5, 2015

Results of SERAPHIN Trial Show Macitentan PAH Treatment Decreases Hospitalization Risk

News, Pulmonary Hypertension

A group of international pulmonary medical specialists have conducted a clinical trial to assess improvement in hospital based outcomes in patients with pulmonary arterial hypertension (PAH) when treated with macitentan, ... Read more